(3R,4R,5S)-4-Acetamido-5-(((9-ethyl-9H-carbazol-3-yl)methyl)-amino)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic Acid

ID: ALA5181442

Chembl Id: CHEMBL5181442

PubChem CID: 168272364

Max Phase: Preclinical

Molecular Formula: C29H37N3O4

Molecular Weight: 491.63

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc3c(c2)c2ccccc2n3CC)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C29H37N3O4/c1-5-21(6-2)36-27-16-20(29(34)35)15-24(28(27)31-18(4)33)30-17-19-12-13-26-23(14-19)22-10-8-9-11-25(22)32(26)7-3/h8-14,16,21,24,27-28,30H,5-7,15,17H2,1-4H3,(H,31,33)(H,34,35)/t24-,27+,28+/m0/s1

Standard InChI Key:  PLDRZAKHURJZGR-HNPKZYAISA-N

Alternative Forms

  1. Parent:

    ALA5181442

    ---

Associated Targets(non-human)

NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 491.63Molecular Weight (Monoisotopic): 491.2784AlogP: 4.77#Rotatable Bonds: 10
Polar Surface Area: 92.59Molecular Species: ZWITTERIONHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.28CX Basic pKa: 8.87CX LogP: 1.81CX LogD: 1.80
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.38Np Likeness Score: 0.15

References

1. Ju H, Murugan NA, Hou L, Li P, Guizzo L, Zhang Y, Bertagnin C, Kong X, Kang D, Jia R, Ma X, Du R, Poongavanam V, Loregian A, Huang B, Liu X, Zhan P..  (2021)  Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability.,  64  (24.0): [PMID:34735766] [10.1021/acs.jmedchem.1c01366]

Source